Skip to main content
. Author manuscript; available in PMC: 2024 Feb 16.
Published in final edited form as: J Adolesc Health. 2023 Oct 15;74(2):301–311. doi: 10.1016/j.jadohealth.2023.08.049

Table 3.

Regression of CMR trajectories on 3-year accumulative indices (Y1-Y3) of trauma and instability

b SE β 95% CI P
Outcome: BMI slope (kg/m2)
 Trauma −0.04 0.05 0.22 −0.14, 0.05 .40
 Instability 0.16 0.05 −0.05 0.08, 0.25 <.001 ***
 Intervention 1 −0.04 0.18 −0.02 −0.38, 0.31 .82
 Intervention 2 0.16 0.17 0.06 −0.17, 0.50 .34
 Child agea −0.01 0.01 −0.05 −0.03, 0.01 .45
 Child sexb −0.16 0.15 −0.07 −0.45, 0.13 .27
 <High schoolc −0.17 0.20 −0.05 −0.55, 0.21 .38
 High school −0.28 0.17 −0.10 −0.61, 0.05 .10
 Baselined 0.02 0.02 0.07 −0.01, 0.05 .22
R2 = 0.08 F(df) = 2.65 (9, 281) <.001 ***
Outcome: HDL slope (mg/dL)
 Trauma −0.14 0.11 −0.07 −0.08, 0.35 .21
 Instability −0.14 0.10 −0.08 −0.33, 0.06 .18
 Intervention 1 −0.16 0.39 −0.03 −0.92, 0.61 .69
 Intervention 2 −0.36 0.38 −0.60 −1.11, 0.39 .35
 Child agea −0.001 0.03 −0.002 −0.05, 0.05 .97
 Child sexb −1.21 0.32 −0.21 −1.85, −0.58 <.001 ***
 <High schoolc −0.37 0.43 −0.05 −1.22, 0.48 .39
 High school 0.21 0.38 0.03 −0.54, 0.95 .59
 Child BMI −0.04 0.03 −0.07 −0.10, 0.02 .21
 Baselined −0.10 0.02 −0.39 −0.12, −0.07 <.001 ***
R2 = 0.20 F(df) = 6.50 (10,272) <.001 ***
Outcome: LDL slope (mg/dL)
 Trauma −0.38 0.27 −0.080 −0.92, 0.15 .16
 Instability 0.19 0.25 0.043 −0.31, 0.68 .46
 Intervention 1 0.69 0.98 0.04 −1.24, 2.62 .48
 Intervention 2 −0.24 0.96 −0.01 −2.14, 1.65 .80
 Child agea −0.04 0.06 −0.04 −0.17, 0.08 .48
 Child sexb −1.56 0.83 −0.10 −3.19, 0.07 .06
 <High schoolc −0.09 1.08 −0.01 −2.22, 2.04 .93
 High school −0.71 0.96 −0.04 −2.59, 1.18 .46
 Child BMI 0.14 0.08 0.10 −0.01, 0.29 .07
 Baselined −0.11 0.02 −0.38 −0.15, −0.08 <.001 ***
R2 = 0.19 F(df) = 5.97 (10,272) <.001 ***
Outcome: BP- systolic slope (%tile)
 Trauma 0.18 0.30 0.03 −0.41, 0.76 .56
 Instability 0.26 0.28 0.05 −0.28, 0.81 .35
 Intervention 1 0.42 1.07 0.02 −1.69, 2.53 .70
 Intervention 2 0.68 1.05 0.04 −1.38, 2.74 .52
 Child agea −0.12 0.07 −0.10 −0.25, 0.01 .08
 Child sexb 2.27 0.90 0.14 0.50, 4.04 .01
 <High schoolc 0.45 1.20 0.02 −1.90, 2.81 .71
 High school −1.06 1.03 −0.06 −3.08, 0.97 .31
 Child BMI 0.33 0.08 0.22 0.17, 0.49 <.001 ***
 Baselined −0.16 0.02 −0.47 −0.19, −0.12 <.001 ***
R2 = 0.24 F(df) = 8.57 (10, 281) <.001 ***
Outcome: BP- diastolic slope (%tile)
 Trauma 0.13 0.23 0.03 −0.33, 0.58 .59
 Instability 0.18 0.22 0.04 −0.25, 0.60 .42
 Intervention 1 0.59 0.85 0.04 −1.08, 2.25 .49
 Intervention 2 −0.03 0.82 −0.002 −1.65, 1.59 .97
 Child agea −0.03 0.05 −0.03 −0.13, 0.08 .60
 Child sexb −1.24 0.71 −0.09 −2.63, 0.15 .08
 <High schoolc 0.71 0.94 0.04 −1.15, 2.57 .45
 High school −1.15 0.81 −0.08 −2.75, 0.46 .16
 Child BMI 0.26 0.07 0.21 0.13, 0.39 <.001 ***
 Baselined −0.18 0.02 −0.54 −0.21, −0.14 <.001 ***
R2 = 0.28 F(df) = 10−0.39 (10, 281) <.001 ***
Outcome: triglycerides slope (mg/dL)
 Trauma −0.01 0.01 −0.05 −0.03, 0.01 .35
 Instability −0.01 0.02 −0.06 −0.06, 0.04 .68
 Intervention 1 −2.05 1.85 −0.06 −5.69, 1.59 .27
 Intervention 2 −1.90 1.81 −0.06 −5.47, 1.67 .30
 Child agea 0.22 0.12 0.10 −0.01, 0.46 .06
 Child sexb 4.48 1.54 0.14 1.44, 7.51 .004 **
 <High schoolc −0.52 2.06 −0.01 −4.57, 3.54 .80
 High school −0.18 1.80 −0.01 −3.72, 3.54 .92
 Child BMI 0.05 0.14 0.02 −0.24, 0.33 .76
 Baselined −0.17 0.02 −0.54 −0.20, −0.14 <.001 ***
R2 = 0.35 F(df) = 14.15 (10, 272) <.001 ***
Outcome: C-reactive protein slope (mg/dL)
 Trauma −0.01 0.01 −0.05 −0.03, 0.01 .35
 Instability −0.01 0.02 −0.06 −0.06, 0.04 .68
 Intervention 1 −0.0001 0.02 <0.001 −0.04, 0.04 .997
 Intervention 2 0.01 0.02 <0.001 −0.02, 0.05 .52
 Child agea −0.0001 0.001 −0.01 −0.002, 0.002 .87
 Child sexb −0.01 0.02 −0.03 −0.04, 0.02 .56
 <High schoolc 0.005 0.02 −0.14 −0.042, 0.042 .81
 High school −0.04 0.02 −0.14 −0.08, −0.01 .01 *
 Child BMI 0.001 0.002 0.14 0.001, 0.007 .02 *
 Baselined −0.18 0.03 −0.44 −0.23, −0.13 <.001 ***
R2 = 0.20 F(df) = 6.44 (10,272) <.001 ***
Outcome: insulin sensitivity slope (mg/dL)
 Trauma 0.001 0.05 0.002 −0.09, 0.09 .98
 Instability −0.01 0.04 −0.01 −0.09, 0.07 .85
 Intervention 1 0.11 0.16 0.04 −0.21, 0.43 .49
 Intervention 2 0.05 0.16 0.01 −0.27, 0.36 .77
 Child agea −0.01 0.01 −0.08 −0.03, 0.01 .18
 Child sexb 0.12 0.14 0.08 −0.08, 0.47 .16
 <High schoolc −0.16 0.18 −0.05 −0.52, 0.19 .37
 High school 0.01 0.16 0.003 −0.30, 0.32 .95
 Child BMI 0.02 0.01 0.11 −0.002, 0.05 .07
 Baselined −0.21 0.03 −0.44 −0.27, −0.16 <.001 ***
R2 = 0.20 F(df) = 6.66 (10,272) <.001 ***

Boldface indicates statistical significance

*

p < .05

**

p < .01

***

p < .001.

BMI = body mass index; CMR = cardiometabolic risk; HDL = high-density lipoprotein.

a

Child age measured in months.

b

Child sex reference group is male.

c

Education reference group is college education or higher.

d

Baseline indicator of the health outcome measured (e.g., baseline [Year 0] BMI when BMI was the outcome).